Exploring the Antimicrobial Properties of Some Selective Mushroom Mycoflora

Mushrooms have long been recognized for their nutritional and medicinal properties, but their potential as sources of antimicrobial agents remains underexplored. This study investigates the antimicrobial activity of various wild mushroom species against selected bacterial and fungal pathogens. Specifically, the study focused on the inhibition zones of <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, <i>Candida albicans</i>, <i>Fusarium oxysporum</i>, and <i>Fusarium proliferatum</i> when exposed to extracts from twelve different mushroom species, including <i>Schizophyllum commune</i>, <i>Laeiporus sulphureus</i>, <i>Pleurotus pulmonarius</i>, and others. The results revealed significant antibacterial and antifungal activities, with <i>Schizophyllum commune</i> showing the highest inhibition against <i>Fusarium oxysporum</i> (71.42 ± 0.28 mm) and <i>Microporus xanthopus</i> demonstrating strong inhibition against <i>Staphylococcus aureus</i> (8.46 ± 0.11 mm). Additionally, <i>Pleurotus sajor-caju</i> exhibited notable antifungal activity against <i>Fusarium proliferatum</i> (76.06 ± 0.14 mm), suggesting its potential as a source of novel antifungal compounds. The study observed a varied range of inhibition zones across different mushroom species, emphasizing the diverse antimicrobial potential within mushroom mycoflora. These findings underscore the importance of further research into the bioactive compounds of mushrooms, which could contribute to the development of new antimicrobial agents. The study not only highlights the significance of mushrooms in combating microbial resistance but also opens avenues for their inclusion in future pharmaceutical applications.